Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 47 studies | 54% ± 21% | |
classical monocyte | 28 studies | 73% ± 13% | |
monocyte | 22 studies | 51% ± 20% | |
non-classical monocyte | 19 studies | 37% ± 15% | |
conventional dendritic cell | 14 studies | 30% ± 10% | |
dendritic cell | 12 studies | 30% ± 19% | |
microglial cell | 12 studies | 48% ± 27% | |
myeloid cell | 12 studies | 52% ± 12% | |
neutrophil | 8 studies | 50% ± 19% | |
alveolar macrophage | 7 studies | 30% ± 11% | |
endothelial cell | 7 studies | 26% ± 6% | |
mononuclear phagocyte | 7 studies | 46% ± 18% | |
intermediate monocyte | 6 studies | 59% ± 20% | |
leukocyte | 5 studies | 25% ± 6% | |
capillary endothelial cell | 4 studies | 35% ± 12% | |
tissue-resident macrophage | 3 studies | 64% ± 15% | |
inflammatory macrophage | 3 studies | 49% ± 9% | |
brush cell | 3 studies | 42% ± 20% | |
progenitor cell of mammary luminal epithelium | 3 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 13659.21 | 226 / 226 | 99% | 539.63 | 403 / 406 |
lung | 99% | 6881.16 | 574 / 578 | 92% | 174.67 | 1067 / 1155 |
breast | 97% | 3390.17 | 443 / 459 | 94% | 146.51 | 1056 / 1118 |
adrenal gland | 100% | 10950.90 | 257 / 258 | 85% | 169.54 | 195 / 230 |
thymus | 85% | 1778.37 | 555 / 653 | 95% | 118.07 | 575 / 605 |
intestine | 92% | 2435.79 | 891 / 966 | 82% | 106.45 | 434 / 527 |
kidney | 69% | 1685.74 | 61 / 89 | 89% | 194.58 | 804 / 901 |
bladder | 86% | 1936.19 | 18 / 21 | 71% | 134.37 | 357 / 504 |
ovary | 63% | 1407.29 | 113 / 180 | 89% | 164.32 | 384 / 430 |
uterus | 64% | 1225.06 | 108 / 170 | 86% | 130.58 | 394 / 459 |
esophagus | 63% | 1439.48 | 911 / 1445 | 74% | 78.01 | 136 / 183 |
stomach | 51% | 1232.86 | 182 / 359 | 83% | 109.37 | 236 / 286 |
brain | 40% | 959.66 | 1055 / 2642 | 89% | 231.02 | 627 / 705 |
prostate | 64% | 1230.06 | 157 / 245 | 64% | 44.61 | 321 / 502 |
pancreas | 35% | 564.09 | 115 / 328 | 92% | 154.16 | 163 / 178 |
skin | 27% | 425.63 | 493 / 1809 | 91% | 205.81 | 430 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 547.41 | 29 / 29 |
adipose | 98% | 6171.28 | 1177 / 1204 | 0% | 0 | 0 / 0 |
spleen | 95% | 6358.49 | 230 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 139.28 | 42 / 45 |
blood vessel | 82% | 3648.93 | 1093 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 18657.11 | 753 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 84.70 | 62 / 80 |
heart | 54% | 1268.59 | 467 / 861 | 0% | 0 | 0 / 0 |
muscle | 10% | 174.94 | 84 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0002752 | Biological process | cell surface pattern recognition receptor signaling pathway |
GO_0071727 | Biological process | cellular response to triacyl bacterial lipopeptide |
GO_0006898 | Biological process | receptor-mediated endocytosis |
GO_0032026 | Biological process | response to magnesium ion |
GO_0071726 | Biological process | cellular response to diacyl bacterial lipopeptide |
GO_0051602 | Biological process | response to electrical stimulus |
GO_0045087 | Biological process | innate immune response |
GO_0031666 | Biological process | positive regulation of lipopolysaccharide-mediated signaling pathway |
GO_0071219 | Biological process | cellular response to molecule of bacterial origin |
GO_0045807 | Biological process | positive regulation of endocytosis |
GO_0032481 | Biological process | positive regulation of type I interferon production |
GO_0034612 | Biological process | response to tumor necrosis factor |
GO_0045471 | Biological process | response to ethanol |
GO_0034145 | Biological process | positive regulation of toll-like receptor 4 signaling pathway |
GO_0071223 | Biological process | cellular response to lipoteichoic acid |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0034142 | Biological process | toll-like receptor 4 signaling pathway |
GO_0006909 | Biological process | phagocytosis |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0006915 | Biological process | apoptotic process |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0046696 | Cellular component | lipopolysaccharide receptor complex |
GO_0010008 | Cellular component | endosome membrane |
GO_0016019 | Molecular function | peptidoglycan immune receptor activity |
GO_0001847 | Molecular function | opsonin receptor activity |
GO_0001875 | Molecular function | lipopolysaccharide immune receptor activity |
GO_0001530 | Molecular function | lipopolysaccharide binding |
GO_0005515 | Molecular function | protein binding |
GO_0070891 | Molecular function | lipoteichoic acid binding |
Gene name | CD14 |
Protein name | Monocyte differentiation antigen CD14 Monocyte differentiation antigen CD14 (Myeloid cell-specific leucine-rich glycoprotein) (CD antigen CD14) [Cleaved into: Monocyte differentiation antigen CD14, urinary form; Monocyte differentiation antigen CD14, membrane-bound form] Monocyte differentiation antigen CD14 (Myeloid cell-specific leucine-rich glycoprotein) |
Synonyms | |
Description | FUNCTION: Coreceptor for bacterial lipopolysaccharide . In concert with LBP, binds to monomeric lipopolysaccharide and delivers it to the LY96/TLR4 complex, thereby mediating the innate immune response to bacterial lipopolysaccharide (LPS) . Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response . Acts as a coreceptor for TLR2:TLR6 heterodimer in response to diacylated lipopeptides and for TLR2:TLR1 heterodimer in response to triacylated lipopeptides, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway . Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-) . . FUNCTION: Coreceptor for bacterial lipopolysaccharide. In concert with LBP, binds to monomeric lipopolysaccharide and delivers it to the LY96/TLR4 complex, thereby mediating the innate immune response to bacterial lipopolysaccharide (LPS). Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Acts as a coreceptor for TLR2:TLR6 heterodimer in response to diacylated lipopeptides and for TLR2:TLR1 heterodimer in response to triacylated lipopeptides, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-). . |
Accessions | D6RFL4 ENST00000519715.2 ENST00000302014.11 ENST00000498971.6 E7EVL5 ENST00000498971.7 ENST00000519715.1 D6RD81 F1C4A7 ENST00000512545.2 P08571 ENST00000512545.1 |